about
The role of MRI in the early diagnosis of Alzheimer’s disease or other dementias in persons with mild cognitive impairment (MCI)How are we going to live with Alzheimer's disease?Mild cognitive impairment: a concept and diagnostic entity in need of input from neuropsychology.DNA-PK and P38 MAPK: A Kinase Collusion in Alzheimer's Disease?Cost-effectiveness of magnetic resonance imaging with a new contrast agent for the early diagnosis of Alzheimer's disease.Differences and the relationship in default mode network intrinsic activity and functional connectivity in mild Alzheimer's disease and amnestic mild cognitive impairmentd-serine levels in Alzheimer's disease: implications for novel biomarker developmentA diagnostic scale for Alzheimer's disease based on cerebrospinal fluid biomarker profiles.Resting state functional connectivity differences between behavioral variant frontotemporal dementia and Alzheimer's disease.Low-density lipoprotein receptor-related protein 1: a physiological Aβ homeostatic mechanism with multiple therapeutic opportunities.Conflicting cerebrospinal fluid biomarkers and progression to dementia due to Alzheimer's disease.Brain activation in frontotemporal and Alzheimer's dementia: a functional near-infrared spectroscopy studyCaenorhabditis elegans as an experimental tool for the study of complex neurological diseases: Parkinson's disease, Alzheimer's disease and autism spectrum disorder.Cerebrospinal fluid biomarkers in Parkinson disease.Atrophy in Alzheimer's Disease and Semantic Dementia: An ALE Meta-Analysis of Voxel-Based Morphometry Studies.A new frontier in spaced retrieval memory training for persons with Alzheimer's disease.The Concept of Prodromal Parkinson's Disease.Intranetwork and internetwork connectivity in patients with Alzheimer disease and the association with cerebrospinal fluid biomarker levels.Regression-Based Norms for the Brief Visuospatial Memory Test-Revised in Italian population and application in MS patients.Differences in structural covariance brain networks between behavioral variant frontotemporal dementia and Alzheimer's disease.Subtle changes in daily functioning predict conversion from normal to mild cognitive impairment or dementia: an analysis of the NACC databaseTablet-Based Functional MRI of the Trail Making Test: Effect of Tablet Interaction Mode.Plasma levels of soluble amyloid precursor protein β in symptomatic Alzheimer's disease.Searching biomarkers for mental disorders-lessons from Alzheimer's disease.Mapping CSF biomarker profiles onto NIA-AA guidelines for Alzheimer's disease.Classification of mild cognitive impairment and Alzheimer disease using model-based MR and magnetization transfer imaging.EEG Markers of Dementia with Lewy Bodies: A Multicenter Cohort Study.Lipidomics Analysis of Behavioral Variant Frontotemporal Dementia: A Scope for Biomarker Development.Emotion Detection Deficits and Decreased Empathy in Patients with Alzheimer's Disease and Parkinson's Disease Affect Caregiver Mood and Burden.Cognitive Reserve Relates to Functional Network Efficiency in Alzheimer's DiseaseCurrently Available Biomarkers and Strategies for the Validation of Novel Candidates for Neurochemical Dementia Diagnostics in Alzheimer’s Disease and Mild Cognitive Impairment
P2860
Q24203748-B556E81E-51EE-4FA4-B6D9-F8D347C51C2BQ27025608-34820E2E-4659-4E4F-9F8D-F2CA57487514Q33688684-767968DB-3D79-47CE-B9E7-33852AB7EC90Q33892330-C6676F95-5F73-46B1-8126-710F0992F95BQ34245127-153A8CB3-42C3-4719-A5DA-3C25F369332FQ34370410-A9A232D4-44C5-43BC-B3FD-9EAD484580BFQ34475073-C93D5F27-DCF7-4BA9-ADC5-45D45EF5CBA9Q34630534-CFC47264-1C94-478C-9B74-7F2E2E2DDF0BQ36033993-C7362B79-D304-43D8-813A-D10A7C2E4DFFQ36205039-3F1014D0-94FF-4047-9024-53F4435F13A9Q37487835-7F625314-A8FF-4B2D-9F38-3D6203082535Q37487950-7637C237-97A3-42C7-9100-4B3314FFE13DQ37954135-4777F103-25BF-493D-A223-73D2F1769FE2Q38082586-5FDD4BBB-A001-4E0D-A846-6AE14E250CD3Q38388339-A44097E1-8D43-490F-B885-A5772A19BBF6Q38476985-F950FBBB-0967-4060-8CFC-6755EDC2C565Q38612230-0A564071-0AFB-4D8D-83B7-AD41612CEE65Q38856483-7FBAFD39-9872-4421-AD44-9BE9C19986E8Q39770183-A10E3253-0809-4384-867B-186941AF2444Q40218298-8371D2B1-2B92-465B-BBC8-373BB9AE4DD1Q41813443-08DD986D-BDA1-487A-9BBE-85E5B529FD82Q47140993-FA90FF81-1297-4175-966D-1E53B1920AD5Q47697345-DADEE9F1-BFD3-4757-A94D-5EF7A1B96EABQ47928238-276DBAE9-2558-4CB1-B7FA-0D8EE6BCC4A6Q48032854-BAC37B6A-9D58-4E49-B76B-1CC72303C98CQ48336882-2477050F-BA35-46C8-8D38-199D2AC098FCQ48469027-8329D236-ABF1-4300-A82F-C33BD69B4A0FQ52655246-04E2C142-D5FB-43E8-BDA2-4B772594B3D8Q54968006-16B5C148-D9D4-4659-BB5B-5644F0CDC3D0Q58728300-51C0B34A-3241-46DB-B7F0-725210D00E4EQ59052213-65D6CB4F-82E3-4F39-83AB-D1E3A98B4C44
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Changing concepts of Alzheimer disease.
@en
Changing concepts of Alzheimer disease.
@nl
type
label
Changing concepts of Alzheimer disease.
@en
Changing concepts of Alzheimer disease.
@nl
prefLabel
Changing concepts of Alzheimer disease.
@en
Changing concepts of Alzheimer disease.
@nl
P356
P1476
Changing concepts of Alzheimer disease.
@en
P2093
Guy M McKhann
P304
P356
10.1001/JAMA.2011.810
P407
P577
2011-06-01T00:00:00Z